annual shareholders equity:
$6.44B+$459.20M(+7.67%)Summary
- As of today (May 29, 2025), UTHR annual stockholders equity is $6.44 billion, with the most recent change of +$459.20 million (+7.67%) on December 31, 2024.
- During the last 3 years, UTHR annual shareholders equity has risen by +$2.49 billion (+62.77%).
- UTHR annual shareholders equity is now at all-time high.
Performance
UTHR Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$6.81B+$363.20M(+5.64%)Summary
- As of today (May 29, 2025), UTHR quarterly stockholders equity is $6.81 billion, with the most recent change of +$363.20 million (+5.64%) on March 31, 2025.
- Over the past year, UTHR quarterly shareholders equity has increased by +$1.47 billion (+27.52%).
- UTHR quarterly shareholders equity is now at all-time high.
Performance
UTHR quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
UTHR Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.7% | +27.5% |
3 y3 years | +62.8% | +63.0% |
5 y5 years | +131.8% | +130.9% |
UTHR Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +62.8% | at high | +63.0% |
5 y | 5-year | at high | +131.8% | at high | +130.9% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
UTHR Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $6.81B(+5.6%) |
Dec 2024 | $6.44B(+7.7%) | $6.44B(+5.6%) |
Sep 2024 | - | $6.10B(+7.1%) |
Jun 2024 | - | $5.70B(+6.7%) |
Mar 2024 | - | $5.34B(-10.8%) |
Dec 2023 | $5.98B(+24.8%) | $5.98B(+4.8%) |
Sep 2023 | - | $5.71B(+5.6%) |
Jun 2023 | - | $5.41B(+5.6%) |
Mar 2023 | - | $5.12B(+6.8%) |
Dec 2022 | $4.80B(+21.2%) | $4.80B(+5.1%) |
Sep 2022 | - | $4.56B(+5.6%) |
Jun 2022 | - | $4.32B(+3.4%) |
Mar 2022 | - | $4.18B(+5.5%) |
Dec 2021 | $3.96B(+16.6%) | $3.96B(+3.4%) |
Sep 2021 | - | $3.83B(+5.2%) |
Jun 2021 | - | $3.64B(+5.6%) |
Mar 2021 | - | $3.45B(+1.5%) |
Dec 2020 | $3.40B(+22.1%) | $3.40B(+3.4%) |
Sep 2020 | - | $3.28B(+6.1%) |
Jun 2020 | - | $3.09B(+4.9%) |
Mar 2020 | - | $2.95B(+6.0%) |
Dec 2019 | $2.78B(-1.0%) | $2.78B(+2.4%) |
Sep 2019 | - | $2.72B(+5.8%) |
Jun 2019 | - | $2.57B(+9.8%) |
Mar 2019 | - | $2.34B(-16.7%) |
Dec 2018 | $2.81B(+32.4%) | $2.81B(+3.5%) |
Sep 2018 | - | $2.71B(+4.9%) |
Jun 2018 | - | $2.58B(+8.2%) |
Mar 2018 | - | $2.39B(+12.6%) |
Dec 2017 | $2.12B(+13.9%) | $2.12B(+1.5%) |
Sep 2017 | - | $2.09B(+16.4%) |
Jun 2017 | - | $1.80B(-13.5%) |
Mar 2017 | - | $2.08B(+11.5%) |
Dec 2016 | $1.86B(+16.4%) | $1.86B(+0.7%) |
Sep 2016 | - | $1.85B(+1.8%) |
Jun 2016 | - | $1.82B(+5.5%) |
Mar 2016 | - | $1.72B(+7.7%) |
Dec 2015 | $1.60B(+26.4%) | $1.60B(+8.1%) |
Sep 2015 | - | $1.48B(+40.4%) |
Jun 2015 | - | $1.05B(-5.3%) |
Mar 2015 | - | $1.11B(-12.1%) |
Dec 2014 | $1.27B(-3.0%) | $1.27B(+4.0%) |
Sep 2014 | - | $1.22B(+0.3%) |
Jun 2014 | - | $1.21B(-10.7%) |
Mar 2014 | - | $1.36B(+4.1%) |
Dec 2013 | $1.30B(+19.1%) | $1.30B(-0.3%) |
Sep 2013 | - | $1.31B(+7.6%) |
Jun 2013 | - | $1.22B(+4.7%) |
Mar 2013 | - | $1.16B(+6.1%) |
Dec 2012 | $1.09B(+14.1%) | $1.09B(+3.2%) |
Sep 2012 | - | $1.06B(+5.1%) |
Jun 2012 | - | $1.01B(-1.5%) |
Mar 2012 | - | $1.02B(+6.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $959.37M(+8.5%) | $959.37M(-11.6%) |
Sep 2011 | - | $1.08B(+8.2%) |
Jun 2011 | - | $1.00B(+8.5%) |
Mar 2011 | - | $924.21M(+4.6%) |
Dec 2010 | $883.89M(+35.4%) | $883.89M(+5.1%) |
Sep 2010 | - | $840.73M(+7.5%) |
Jun 2010 | - | $782.30M(+7.4%) |
Mar 2010 | - | $728.25M(+11.5%) |
Dec 2009 | $653.01M(+17.6%) | $653.01M(+2.1%) |
Sep 2009 | - | $639.56M(+5.7%) |
Jun 2009 | - | $604.98M(+4.8%) |
Mar 2009 | - | $577.28M(+4.0%) |
Dec 2008 | $555.33M(+87.7%) | $555.33M(+32.7%) |
Sep 2008 | - | $418.59M(+15.2%) |
Jun 2008 | - | $363.41M(+11.3%) |
Mar 2008 | - | $326.43M(+10.4%) |
Dec 2007 | $295.79M(+44.6%) | $295.79M(+40.5%) |
Sep 2007 | - | $210.54M(+17.6%) |
Jun 2007 | - | $179.00M(+10.3%) |
Mar 2007 | - | $162.35M(-20.7%) |
Dec 2006 | $204.61M(-25.6%) | $204.61M(-25.6%) |
Sep 2006 | - | $275.05M(-8.2%) |
Jun 2006 | - | $299.52M(+5.0%) |
Mar 2006 | - | $285.29M(+3.7%) |
Dec 2005 | $275.10M(+43.6%) | $275.10M(+15.4%) |
Sep 2005 | - | $238.36M(+9.9%) |
Jun 2005 | - | $216.80M(+6.6%) |
Mar 2005 | - | $203.31M(+6.1%) |
Dec 2004 | $191.64M(+14.2%) | $191.64M(+6.9%) |
Sep 2004 | - | $179.34M(+5.1%) |
Jun 2004 | - | $170.59M(+3.4%) |
Mar 2004 | - | $165.05M(-1.6%) |
Dec 2003 | $167.76M(-2.3%) | $167.76M(-1.1%) |
Sep 2003 | - | $169.55M(+0.0%) |
Jun 2003 | - | $169.47M(+0.7%) |
Mar 2003 | - | $168.31M(-1.9%) |
Dec 2002 | $171.66M(-12.6%) | $171.66M(-1.4%) |
Sep 2002 | - | $174.11M(-6.4%) |
Jun 2002 | - | $186.04M(-2.5%) |
Mar 2002 | - | $190.80M(-2.8%) |
Dec 2001 | $196.40M(-16.3%) | $196.40M(-3.5%) |
Sep 2001 | - | $203.57M(-4.7%) |
Jun 2001 | - | $213.59M(-5.0%) |
Mar 2001 | - | $224.79M(-4.2%) |
Dec 2000 | $234.74M(+337.9%) | $234.74M(-3.3%) |
Sep 2000 | - | $242.77M(+111.5%) |
Jun 2000 | - | $114.81M(-7.1%) |
Mar 2000 | - | $123.58M(+130.6%) |
Dec 1999 | $53.60M(+221.0%) | $53.60M(-9.8%) |
Sep 1999 | - | $59.40M(+1.9%) |
Jun 1999 | - | $58.30M(+276.1%) |
Mar 1999 | - | $15.50M |
Dec 1998 | $16.70M | - |
FAQ
- What is United Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for United Therapeutics?
- What is United Therapeutics annual shareholders equity year-on-year change?
- What is United Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for United Therapeutics?
- What is United Therapeutics quarterly shareholders equity year-on-year change?
What is United Therapeutics annual stockholders equity?
The current annual shareholders equity of UTHR is $6.44B
What is the all time high annual shareholders equity for United Therapeutics?
United Therapeutics all-time high annual stockholders equity is $6.44B
What is United Therapeutics annual shareholders equity year-on-year change?
Over the past year, UTHR annual stockholders equity has changed by +$459.20M (+7.67%)
What is United Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of UTHR is $6.81B
What is the all time high quarterly shareholders equity for United Therapeutics?
United Therapeutics all-time high quarterly stockholders equity is $6.81B
What is United Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, UTHR quarterly stockholders equity has changed by +$1.47B (+27.52%)